Zhang J W, Chen L B, Yang M, et al. Novel theory and methods for chemomic multi-component release/dissolution kinetics of traditional Chinese medicines [J]. Chin J Nat Med, 2008, 6:48.
[11]
Chen L B, Wang Z H, Fu D D, et al. Application of chemomic release kinetics to evaluation of the release characteristics of Yinqiaojiedu tablets [J]. Chin J Nat Med, 2008, 6:450.
Avachat A M, Bornare P N, Dash R R. Sustained release microspheres of ropinirolehydrochloride: effect of process parameters[J]. Acta Pharm, 2011, 61(4):363.
[15]
Shapur N K, Duvdevani M, Friedman M, et al. Second prize: sustained release varnish containing chlorhexidine for prevention of biofilm formation on urinary catheter surface: in vitro study[J]. J Endourol, 2012, 26(1):26.
[16]
Sathiyaraj S, Devi R D, Hari V B. Lornoxicam gastro retentive floating matrix tablets: design and in vitro evaluation[J]. J Adv Pharm Technol Res, 2011, 2(3):156.
[17]
Jiskoot W, Randolph T W, Volkin D B, et al. Protein instability and immunogenicity: roadblocks to clinical application of injectable protein delivery systems for sustained release[J]. J Pharm Sci, 2012, 101(3):946.
[18]
Vidanagamage R S, Goonewardene I M. The efficacy of two different doses of vaginal isosorbidemononitrate in preinduction cervical ripening: a double blind randomised controlled trial[J]. Ceylon Med J, 2011, 56(3):91.
Amidon G L, LennernasH, Shah V P, et al. A theroretical basis for biopharmaceutical drug classification system: the correlation of dissolution and in vivo bioavailability[J]. Pharm Res, 1995, 12(3):413.
[25]
FDA Center for Drug Evaluation and Research. Guidance for industry: waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceuticals classification system. 2000-01-13. http//www.fda.gov/cder/guidance/3618fnl.pdf.
[26]
平其能. 中药成分的胃肠转运与剂型设计[M]. 北京:化学工业出版社, 2010.
[27]
Li Z Q, He X, Gao X, et al. Study on dissolution and absorption of four dosage forms of isosorbidemononitrate: level Ain vitro-in vivo correlation[J]. Eur J Pharm Biopharm, 2011, 79(2): 364.
[28]
He X, Kadomura S, Takekuma Y, et al. A new system forthe prediction of drug absorption using a pH-controlled Caco-2 model: evaluation of pH-dependent soluble drugabsorption and pH-related changes in absorption[J]. J Pharm Sci, 2004, 93 (1):71.
